Novartis Brand Ranking

NOVARTIS

Beijing Novartis Pharma Ltd.

Industry： Lithium carbonate , Pudilan anti-inflammatory tablets , drug , Athletic foot ointment , Raw materials , Chemical drugs , medicine , Medical Optical Instruments , Medical Science

If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.

NOVARTIS

Beijing Novartis Pharma Ltd.

Industry： Lithium carbonate , Pudilan anti-inflammatory tablets , drug , Athletic foot ointment , Raw materials , Chemical drugs , medicine , Medical Optical Instruments , Medical Science

If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.

Brand Introduction

Novartis ' history can be traced back to three companies that have intersections with it. Gargi established a trading of chemicals and dyes in Basel, Switzerland in the mid-18th century; Ciba began to produce dyes in 1859; Sandoz in 1886 2019 a chemical company was established in Basel. Later, Novartis was formed by the merger of these three companies in 1996. With its predecessor's long and rich experience in developing innovative products, it developed from its initial focus on the production and synthesis of fiber fabric dyes and became a focus on chemistry The world's largest pharmaceutical and health enterprise of product and medicine.

Novartis is one of the three largest pharmaceutical companies in the world. Its headquarters is located in Basel, Switzerland. Its business covers more than 150 countries and regions around the world and has 138,000 employees.

Novartis is committed to providing innovative medical and healthcare solutions to patients and society to meet their changing health needs, focusing on the four core therapeutic areas where patients need urgently (cardiovascular, kidney and metabolism, tumors, immune, neuroscience) and the five major Technology platforms (chemotherapy, biotherapy, xRNA therapy, radioligand therapy, gene and cell therapy) continue to develop pioneering therapies. It has a diversified product portfolio, with business departments including innovative drugs (Novartis), ophthalmic health care (Alcon), generic drugs (Sandus), vaccines, and animal health products.

The Novartis China headquarters was established in 1997. Its name is "Promise for China", which means improving the health level and quality of life of the Chinese people through continuous innovative products and services. China is one of Novartis' major strategic markets around the world. Novartis has laid out its Chinese market from R&D, production to business development, and has built production bases in Changping, Beijing, and established R&D institutions in Beijing, Shanghai and Jiangsu.

Since 1987, Novartis has approved about 100 innovative drugs and new indications in China. In order to accelerate the introduction of innovative drugs, since 2022, Novartis' new drugs and new indications in China have achieved 100% sync with the world; at the same time, Novartis actively promotes the accessibility of innovative drugs, and since 2017, more than 30 have been reported. The drug has been included in the national medical insurance catalog.

Related Keywords: NOVARTIS Lithium carbonate , NOVARTIS Pudilan anti-inflammatory tablets , NOVARTIS drug , NOVARTIS Athletic foot ointment , NOVARTIS Raw materials , NOVARTIS Chemical drugs , NOVARTIS medicine , NOVARTIS Medical Optical Instruments , NOVARTIS Medical Science

Related Brand: Guoxuan High - Tech Co., Ltd. , Ganfeng Lithium Co., Ltd. , YANHU SHARE , Zangge Mining , Zhicun Lithium Industry , Ruifu Lithium Industry , SINOMINE , Yinli New Energy , Western Mine , Tianqi Lithium

Recommend Related Products